The Valley Desk

NCT01578239 · Interventional trial

A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours

Overall registry status Completed

Phase 3

Conditions Carcinoid Tumor of the Small Bowel, Neuroendocrine Tumour

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov